Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses. (Q55461456)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
scientific article

    Statements

    Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses. (English)
    1 reference
    12 October 2019
    1 reference
    18 October 2019
    2 references
    1 August 2020
    1 reference
    2 October 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit